Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Perry

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
American Journal of Hospital Pharmacy|August 1, 1977
Amphetamine psychosisP J Perry, R P Juhl
Mini Reviews in Medicinal Chemistry|October 9, 2002
DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibitionP J Perry, T C Jenkins
DICP : the Annals of Pharmacotherapy|April 1, 1990
Triazolam--an "abused drug" by the lay press?P J Schneider, P J Perry
Journal of Clinical Psychopharmacology|August 1, 1994
Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of responseP J Perry, C Zeilmann, S Arndt
Pharmacotherapy|July 25, 2000
Diabetes mellitus associated with clozapine therapyH Wehring, B Alexander, P J Perry
Journal of Clinical Psychopharmacology|December 31, 1997
Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patientsP J Perry, T Sanger, C Beasley
The American Journal of Psychiatry|December 1, 1996
SteroidsW R Yates, P J Perry, V Ellingrod
The American Journal of Psychiatry|January 20, 1998
Haloperidol plasma levels and dose optimizationW Coryell, D D Miller, P J Perry
American Journal of Hospital Pharmacy|August 1, 1980
Lithium citrate syrup and trifluoperazine hydrochloride concentrate incompatibility: effect on serum lithium levelsJ L McGee, B Alexander, P J Perry
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Amoxapine neurotoxicity: a case report with long-term follow-upJ L Browne, M T Tsuang, P J Perry
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
American Journal of Hospital Pharmacy|August 1, 1977
Amphetamine psychosisP J Perry, R P Juhl
Mini Reviews in Medicinal Chemistry|October 9, 2002
DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibitionP J Perry, T C Jenkins
DICP : the Annals of Pharmacotherapy|April 1, 1990
Triazolam--an "abused drug" by the lay press?P J Schneider, P J Perry
Journal of Clinical Psychopharmacology|August 1, 1994
Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of responseP J Perry, C Zeilmann, S Arndt
Pharmacotherapy|July 25, 2000
Diabetes mellitus associated with clozapine therapyH Wehring, B Alexander, P J Perry
Journal of Clinical Psychopharmacology|December 31, 1997
Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patientsP J Perry, T Sanger, C Beasley
The American Journal of Psychiatry|December 1, 1996
SteroidsW R Yates, P J Perry, V Ellingrod
The American Journal of Psychiatry|January 20, 1998
Haloperidol plasma levels and dose optimizationW Coryell, D D Miller, P J Perry
American Journal of Hospital Pharmacy|August 1, 1980
Lithium citrate syrup and trifluoperazine hydrochloride concentrate incompatibility: effect on serum lithium levelsJ L McGee, B Alexander, P J Perry
Drug Intelligence & Clinical Pharmacy|May 1, 1982
Amoxapine neurotoxicity: a case report with long-term follow-upJ L Browne, M T Tsuang, P J Perry
Pageof 13